David Bumcrot - Oct 10, 2024 Form 3 Insider Report for Camp4 Therapeutics Corp (CAMP)

Role
Chief Scientific Officer
Signature
By: /s/ Thomas Danielski, Attorney-in-Fact
Stock symbol
CAMP
Transactions as of
Oct 10, 2024
Transactions value $
$0
Form type
3
Date filed
10/10/2024, 09:03 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CAMP Common Stock 61.7K Oct 10, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CAMP Stock Option (Right to Buy) Oct 10, 2024 Common Stock 47 $2.12 Direct F1
holding CAMP Stock Option (Right to Buy) Oct 10, 2024 Common Stock 5.01K $2.12 Direct F1
holding CAMP Stock Option (Right to Buy) Oct 10, 2024 Common Stock 661 $2.12 Direct F1
holding CAMP Stock Option (Right to Buy) Oct 10, 2024 Common Stock 567 $2.12 Direct F1
holding CAMP Stock Option (Right to Buy) Oct 10, 2024 Common Stock 4.35K $2.12 Direct F1
holding CAMP Stock Option (Right to Buy) Oct 10, 2024 Common Stock 4.2K $2.12 Direct F1
holding CAMP Stock Option (Right to Buy) Oct 10, 2024 Common Stock 15.6K $5.50 Direct F2
holding CAMP Stock Option (Right to Buy) Oct 10, 2024 Common Stock 87.6K $8.41 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable as of the date hereof.
F2 This option had a vesting start date of March 1, 2022 and vests in equal monthly installments over 48 months, beginning on the one-month anniversary of the vesting start date.
F3 This option had a vesting start date of September 1, 2022 and vests in equal monthly installments over 48 months, beginning on the one-month anniversary of the vesting start date.

Remarks:

Exhibit 24 - Power of Attorney